CHEDIAK-HIGASHI SYNDROME

 

CHEDIAK-HIGASHI SYNDROME

 

DEFINITION:

A generalized cellular disorder which affects all granule-containing cells resulting in recurrent infections and ocular, neurological, and skin manifestations.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • early childhood
  • risk factors:
    • familial - autosomal recessive
      • chrom.#: ?
      • gene: ?

PATHOGENESIS:

1. Genetic Defect

  • gene defect -> abnormal membrane fluidity -> uncontrolled granule membrane fusion -> formation of giant cytoplasmic granules in all granule-containing cells -> generalized disease:

1. Neutrophils

  • progressive coalescence of azurophilic and specific granules during myelopoiesis in the bone marrow -> formation of giant azurophil and specific granules results in:
    • death of myeloid precursors in the bone marrow re-sulting in a neutropenia
    • defective chemotaxis, degranulation, and bactericidal activity of the remaining neutrophils
      • inability of neutrophils to move normally
      • delayed fusion of abnormal granules with phagosomes containing ingested microbes - inability to concentrate hydrolytic enzymes into neutrophil lysosomes (i.e., cathepsins, elastase)
      • reduced iC3b receptor expression
    • increased susceptibility to infection
      • especially gram + and - bacteria
      • S. aureus and beta-hemolytic Strep. isolated most frequently

2. Other Hematological Cells

1. Lymphocytes

  • function poorly in antibody-dependent cell-mediated cytolysis of tumor cells

2. Platelets

  • unable to concentrate seritonin and ADP -> storage pool deficiency of seritonin and ADP -> platelet aggregation defect -> normal platelet concentration but prolonged bleeding time

3. Others

  • defects noted in monocytes, macrophages, and natural killer cells

3. Melanocytes

  • failure to dispense pigment -> contain giant melanosomes -> partial albinism of hair and skin and silver-tinged hair

4. Other Cells

  • Schwann cells - central and peripheral neuropathies
  • Retinal cells - photophobia, nystagmus, altered red reflex
  • Fibroblasts

CLINICAL FEATURES:

1. Recurrent Infections

  • increased susceptibility to recurrent infections
    • skin, respiratory tract, chronic cough
    • mucous membranes (gingivitis, peridontitis)

2. Ocular Manifestations

  • usually the presenting complaint or finding
  • extreme photophobia, rotary nystagmus, increase red reflex

3. Neurological Manifestations

  • onset in adulthood
  • motor, sensory, and cranial nerve neurologic defects
    • ataxia, muscular weakness
  • seizures

4. Skin Manifestations

  • partial albinism
  • hair colour varies from blond to dark brown but has a silvery tint in bright light

5. Complications

1. Accelerated Phase

  • occurs in 85% of patients
  • an EBV or other lymphotrophic viral infection may initiate this phase characterized by a lymphoma-like picture with fever, generalized lymphadenopathy, hepatosplenomegaly, (hepatomegaly), pancytopenia, and sepsis (a viral infection may stimulate lymphohistiocytic proliferation within the reticuloendothelial system)

INVESTIGATIONS:

1. CBC

  • 2,000-15,000 WBC's (50-70% PMN's)
  • normal platelet count but prolonged bleeding time
  • pancytopenia in accelerated phase

2. Neutrophil Function

  • chemotaxis - decreased
  • superoxide release - increased
  • bacterial killing
    • moderately decreased

3. Cytochemistry (Wright Stain)

  • giant granules

4. Prenatal Diagnosis

  • giant neutrophil granules present in fetal blood

MANAGEMENT:

1. Stable Phase

1. Multidisciplinary approach

  • Paediatrics, Dermatology, Neurology, Ophthalmology, OT, PT
  • management of infections and seizures
  • no role for prophylactic antibiotics
  • ascorbic acid may improve the clinical status and phagocytic function

2. Accelerated Phase

1. corticosteroids, vincristine, cyclophosphamide

  • may partially arrest the lymphohistiocytic infiltration of the reticuloendothelial system but is not effective in arresting the progression of the disease

2. acyclovir and prednisone

  • may provide temporary improvement in fever, pancytopenia, and decrease the bleeding time

3. bone marrow transplantation

  • has been successful

 

 

Pediatric Database - CHEDIAK-HIGASHI SYNDROME

Pediatric Organization - Pedbase [at] Gmail.com